Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Hepatitis B virus | 13 | 2019 | 882 | 3.37 | Why? |
Hepatitis B | 9 | 2019 | 888 | 2.53 | Why? |
Hepatitis B, Chronic | 8 | 2019 | 616 | 2.08 | Why? |
Hepatocytes | 7 | 2019 | 549 | 0.95 | Why? |
Hepatitis B Vaccines | 2 | 2018 | 245 | 0.72 | Why? |
Hepatitis C | 2 | 2019 | 1514 | 0.64 | Why? |
Lipase | 1 | 2018 | 153 | 0.63 | Why? |
Immunotherapy | 2 | 2018 | 2421 | 0.54 | Why? |
Hepatitis E virus | 1 | 2017 | 306 | 0.51 | Why? |
Hepacivirus | 2 | 2019 | 1509 | 0.44 | Why? |
Liver Neoplasms | 4 | 2017 | 1666 | 0.44 | Why? |
Carcinoma, Hepatocellular | 3 | 2017 | 1222 | 0.44 | Why? |
RNA | 1 | 2017 | 1278 | 0.39 | Why? |
Hepatitis C, Chronic | 1 | 2019 | 973 | 0.39 | Why? |
Host-Pathogen Interactions | 4 | 2021 | 11041 | 0.38 | Why? |
Hepatitis Delta Virus | 2 | 2019 | 54 | 0.37 | Why? |
Kupffer Cells | 2 | 2018 | 34 | 0.36 | Why? |
Organic Anion Transporters, Sodium-Dependent | 2 | 2017 | 26 | 0.35 | Why? |
Adaptive Immunity | 2 | 2021 | 2585 | 0.34 | Why? |
HLA-B Antigens | 2 | 2019 | 166 | 0.34 | Why? |
Symporters | 2 | 2017 | 80 | 0.33 | Why? |
Hepatitis B Surface Antigens | 3 | 2017 | 305 | 0.33 | Why? |
Liver Cirrhosis | 2 | 2017 | 1810 | 0.32 | Why? |
Interferons | 1 | 2019 | 2885 | 0.32 | Why? |
Antiviral Agents | 6 | 2021 | 41703 | 0.31 | Why? |
Family | 1 | 2020 | 2909 | 0.31 | Why? |
Interferon Type I | 1 | 2019 | 2789 | 0.30 | Why? |
DNA, Circular | 2 | 2019 | 26 | 0.24 | Why? |
Immunity, Innate | 2 | 2018 | 6570 | 0.22 | Why? |
DNA, Viral | 4 | 2019 | 2521 | 0.21 | Why? |
Gliosis | 1 | 2019 | 16 | 0.21 | Why? |
Chemokine CCL19 | 1 | 2019 | 22 | 0.21 | Why? |
Diagnostic Equipment | 1 | 2020 | 41 | 0.21 | Why? |
CD8-Positive T-Lymphocytes | 4 | 2019 | 5837 | 0.21 | Why? |
Interferon-alpha | 2 | 2019 | 1442 | 0.20 | Why? |
Hepatitis D, Chronic | 1 | 2019 | 16 | 0.20 | Why? |
Primary Cell Culture | 2 | 2018 | 501 | 0.20 | Why? |
Central Nervous System Neoplasms | 1 | 2019 | 88 | 0.19 | Why? |
Hepatitis delta Antigens | 1 | 2018 | 6 | 0.19 | Why? |
Cytokines | 3 | 2021 | 15010 | 0.19 | Why? |
Hepatic Stellate Cells | 1 | 2018 | 35 | 0.19 | Why? |
Immunologic Surveillance | 1 | 2019 | 69 | 0.19 | Why? |
Mucosal-Associated Invariant T Cells | 1 | 2021 | 170 | 0.19 | Why? |
Infarction, Middle Cerebral Artery | 1 | 2021 | 203 | 0.18 | Why? |
Hepatitis D | 1 | 2018 | 48 | 0.18 | Why? |
N-Glycosyl Hydrolases | 1 | 2017 | 19 | 0.18 | Why? |
Protein-Arginine N-Methyltransferases | 1 | 2017 | 12 | 0.18 | Why? |
Cell Polarity | 1 | 2018 | 85 | 0.18 | Why? |
Receptors, Pattern Recognition | 1 | 2018 | 128 | 0.17 | Why? |
DNA Repair | 1 | 2017 | 114 | 0.17 | Why? |
Cytidine Deaminase | 1 | 2017 | 109 | 0.17 | Why? |
HLA-A Antigens | 1 | 2019 | 196 | 0.17 | Why? |
Cell Line, Tumor | 4 | 2019 | 3608 | 0.17 | Why? |
DNA Replication | 1 | 2017 | 121 | 0.16 | Why? |
Hepatitis, Viral, Animal | 1 | 2018 | 274 | 0.16 | Why? |
Apolipoproteins E | 1 | 2018 | 170 | 0.16 | Why? |
Immune Tolerance | 2 | 2019 | 608 | 0.16 | Why? |
Lipoproteins | 1 | 2018 | 240 | 0.16 | Why? |
Mutant Proteins | 1 | 2017 | 328 | 0.15 | Why? |
Activation, Metabolic | 1 | 2014 | 6 | 0.15 | Why? |
Macaca | 1 | 2017 | 388 | 0.15 | Why? |
Cells, Cultured | 4 | 2019 | 5835 | 0.15 | Why? |
Germany | 5 | 2021 | 9196 | 0.14 | Why? |
Liver | 3 | 2018 | 4007 | 0.14 | Why? |
Cholangiocarcinoma | 1 | 2017 | 186 | 0.14 | Why? |
MAP Kinase Signaling System | 1 | 2017 | 360 | 0.14 | Why? |
Neoplasm Metastasis | 1 | 2018 | 682 | 0.14 | Why? |
Bile Duct Neoplasms | 1 | 2017 | 172 | 0.14 | Why? |
Lymphoma | 1 | 2019 | 522 | 0.13 | Why? |
Superinfection | 1 | 2019 | 459 | 0.13 | Why? |
Models, Animal | 1 | 2017 | 788 | 0.13 | Why? |
Lymphocyte Activation | 2 | 2021 | 2742 | 0.13 | Why? |
Immunization, Secondary | 1 | 2021 | 1649 | 0.13 | Why? |
Interferon-beta | 1 | 2019 | 979 | 0.12 | Why? |
Lipid Metabolism | 1 | 2018 | 572 | 0.12 | Why? |
Leupeptins | 1 | 2012 | 49 | 0.12 | Why? |
Calpain | 1 | 2012 | 39 | 0.12 | Why? |
Infectious Disease Incubation Period | 1 | 2020 | 1033 | 0.12 | Why? |
Hepatitis E | 1 | 2017 | 319 | 0.12 | Why? |
Travel-Related Illness | 1 | 2020 | 1357 | 0.12 | Why? |
Communicable Diseases, Imported | 1 | 2020 | 843 | 0.11 | Why? |
Transcription, Genetic | 1 | 2017 | 1326 | 0.11 | Why? |
Tumor Necrosis Factor-alpha | 2 | 2021 | 2483 | 0.11 | Why? |
Proteome | 1 | 2021 | 1812 | 0.11 | Why? |
Fatty Liver | 1 | 2014 | 299 | 0.10 | Why? |
Humans | 36 | 2021 | 930598 | 0.10 | Why? |
Epitopes, T-Lymphocyte | 2 | 2019 | 2262 | 0.10 | Why? |
Virus Replication | 3 | 2017 | 14331 | 0.10 | Why? |
Metal Nanoparticles | 1 | 2017 | 771 | 0.10 | Why? |
Proteomics | 1 | 2021 | 2481 | 0.10 | Why? |
Antigens, Viral | 3 | 2021 | 6298 | 0.10 | Why? |
Animals | 12 | 2021 | 78931 | 0.10 | Why? |
Killer Cells, Natural | 2 | 2021 | 2093 | 0.09 | Why? |
Mice | 6 | 2019 | 21357 | 0.09 | Why? |
Swine | 1 | 2017 | 3352 | 0.09 | Why? |
Endothelial Cells | 1 | 2018 | 2048 | 0.09 | Why? |
Drug Discovery | 2 | 2018 | 3092 | 0.08 | Why? |
Macrophages | 1 | 2018 | 2784 | 0.08 | Why? |
Cysteine Proteinase Inhibitors | 1 | 2012 | 675 | 0.07 | Why? |
Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
False Negative Reactions | 2 | 2021 | 1785 | 0.07 | Why? |
SARS Virus | 2 | 2021 | 13021 | 0.06 | Why? |
Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
Biosensing Techniques | 1 | 2017 | 2116 | 0.06 | Why? |
Aging | 1 | 2019 | 3581 | 0.06 | Why? |
Sensitivity and Specificity | 5 | 2021 | 22971 | 0.06 | Why? |
Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.06 | Why? |
Cell Line | 4 | 2021 | 12040 | 0.06 | Why? |
Viral Load | 2 | 2020 | 15850 | 0.06 | Why? |
Mice, Inbred C57BL | 3 | 2018 | 5542 | 0.06 | Why? |
Immobilized Proteins | 1 | 2021 | 47 | 0.06 | Why? |
Child, Preschool | 3 | 2021 | 36283 | 0.06 | Why? |
Matrix Metalloproteinase Inhibitors | 1 | 2021 | 45 | 0.06 | Why? |
Mice, Transgenic | 2 | 2019 | 2739 | 0.06 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
Virus Internalization | 2 | 2018 | 7921 | 0.05 | Why? |
Angiography, Digital Subtraction | 1 | 2021 | 123 | 0.05 | Why? |
Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
Granzymes | 1 | 2021 | 197 | 0.05 | Why? |
Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 8 | 0.05 | Why? |
Time-Lapse Imaging | 1 | 2019 | 28 | 0.05 | Why? |
Receptors, CCR7 | 1 | 2019 | 40 | 0.05 | Why? |
Intravital Microscopy | 1 | 2019 | 34 | 0.05 | Why? |
Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
Mechanical Thrombolysis | 1 | 2021 | 150 | 0.05 | Why? |
Chemokine CXCL12 | 1 | 2019 | 74 | 0.05 | Why? |
Autophagy | 2 | 2021 | 960 | 0.05 | Why? |
Ubiquitination | 1 | 2021 | 343 | 0.05 | Why? |
Automation | 1 | 2021 | 429 | 0.05 | Why? |
Cellular Microenvironment | 1 | 2018 | 55 | 0.05 | Why? |
Transforming Growth Factor beta | 1 | 2021 | 363 | 0.05 | Why? |
HLA-DR Antigens | 1 | 2021 | 563 | 0.05 | Why? |
Blotting, Southern | 1 | 2017 | 18 | 0.04 | Why? |
Butylated Hydroxyanisole | 1 | 2017 | 5 | 0.04 | Why? |
Automation, Laboratory | 1 | 2021 | 536 | 0.04 | Why? |
Pathogen-Associated Molecular Pattern Molecules | 1 | 2018 | 108 | 0.04 | Why? |
Epidemics | 1 | 2018 | 6407 | 0.04 | Why? |
Receptors, Tumor Necrosis Factor | 1 | 2017 | 40 | 0.04 | Why? |
Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
Hepatitis B Core Antigens | 1 | 2017 | 76 | 0.04 | Why? |
Protein Processing, Post-Translational | 1 | 2021 | 634 | 0.04 | Why? |
Neoplastic Cells, Circulating | 1 | 2018 | 68 | 0.04 | Why? |
Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
Phosphorylation | 1 | 2021 | 1060 | 0.04 | Why? |
Lab-On-A-Chip Devices | 1 | 2021 | 411 | 0.04 | Why? |
Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
Severe Acute Respiratory Syndrome | 1 | 2021 | 12361 | 0.04 | Why? |
Infant | 1 | 2020 | 30274 | 0.04 | Why? |
Astrocytes | 1 | 2019 | 298 | 0.04 | Why? |
Sequence Homology | 1 | 2018 | 448 | 0.04 | Why? |
Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
Tissue Culture Techniques | 1 | 2017 | 158 | 0.04 | Why? |
Prealbumin | 1 | 2018 | 203 | 0.04 | Why? |
Immune Sera | 1 | 2021 | 884 | 0.04 | Why? |
Immunoprecipitation | 1 | 2017 | 300 | 0.04 | Why? |
Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
Magnetite Nanoparticles | 1 | 2017 | 109 | 0.04 | Why? |
Antigens | 1 | 2018 | 267 | 0.04 | Why? |
Epigenomics | 1 | 2017 | 139 | 0.04 | Why? |
Biopsy, Needle | 1 | 2017 | 303 | 0.04 | Why? |
Hep G2 Cells | 1 | 2017 | 391 | 0.04 | Why? |
Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.04 | Why? |
Interleukin-17 | 1 | 2021 | 602 | 0.04 | Why? |
RNA, Viral | 3 | 2020 | 32276 | 0.04 | Why? |
Luminescent Measurements | 1 | 2021 | 924 | 0.04 | Why? |
False Positive Reactions | 1 | 2021 | 1338 | 0.04 | Why? |
Tumor Microenvironment | 1 | 2017 | 264 | 0.04 | Why? |
Adult | 7 | 2021 | 244371 | 0.04 | Why? |
Blood-Brain Barrier | 1 | 2019 | 531 | 0.04 | Why? |
Carcinogenesis | 1 | 2017 | 236 | 0.04 | Why? |
CHO Cells | 1 | 2017 | 831 | 0.04 | Why? |
Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
Promoter Regions, Genetic | 1 | 2018 | 823 | 0.03 | Why? |
Cricetulus | 1 | 2017 | 936 | 0.03 | Why? |
Mutation | 3 | 2020 | 12376 | 0.03 | Why? |
Cell Movement | 1 | 2018 | 695 | 0.03 | Why? |
Datasets as Topic | 1 | 2021 | 1404 | 0.03 | Why? |
Protein Interaction Maps | 1 | 2021 | 1333 | 0.03 | Why? |
Autophagy-Related Protein 5 | 1 | 2012 | 28 | 0.03 | Why? |
Cytomegalovirus | 1 | 2018 | 600 | 0.03 | Why? |
T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
Gold | 1 | 2017 | 592 | 0.03 | Why? |
Alleles | 1 | 2019 | 1557 | 0.03 | Why? |
Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
Adenoviridae | 1 | 2018 | 1151 | 0.03 | Why? |
Recombinant Fusion Proteins | 1 | 2017 | 919 | 0.03 | Why? |
NF-kappa B | 1 | 2019 | 1301 | 0.03 | Why? |
Disease Eradication | 1 | 2018 | 581 | 0.03 | Why? |
Female | 7 | 2021 | 380317 | 0.03 | Why? |
Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.03 | Why? |
Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
Polymorphism, Genetic | 1 | 2019 | 1074 | 0.03 | Why? |
Gene Knockdown Techniques | 1 | 2012 | 347 | 0.03 | Why? |
Microtubule-Associated Proteins | 1 | 2012 | 187 | 0.03 | Why? |
Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
Amino Acid Substitution | 1 | 2018 | 1706 | 0.03 | Why? |
Protein Kinase Inhibitors | 1 | 2021 | 1585 | 0.03 | Why? |
Proteasome Endopeptidase Complex | 1 | 2012 | 249 | 0.03 | Why? |
Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
Interviews as Topic | 1 | 2020 | 1952 | 0.03 | Why? |
Disease Models, Animal | 2 | 2019 | 10998 | 0.03 | Why? |
Computed Tomography Angiography | 1 | 2021 | 2153 | 0.03 | Why? |
Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
Mitochondria | 1 | 2017 | 857 | 0.03 | Why? |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.02 | Why? |
Proteins | 1 | 2017 | 921 | 0.02 | Why? |
Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.02 | Why? |
Male | 5 | 2021 | 367725 | 0.02 | Why? |
Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.02 | Why? |
Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
Interferon-gamma | 1 | 2019 | 2711 | 0.02 | Why? |
Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
RNA, Small Interfering | 1 | 2012 | 817 | 0.02 | Why? |
Macaca mulatta | 1 | 2017 | 3716 | 0.02 | Why? |
Laboratories | 1 | 2020 | 2858 | 0.02 | Why? |
Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
Serologic Tests | 1 | 2021 | 4359 | 0.02 | Why? |
Amino Acid Sequence | 1 | 2018 | 6049 | 0.02 | Why? |
Feces | 1 | 2020 | 4235 | 0.02 | Why? |
Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
Evolution, Molecular | 1 | 2019 | 3691 | 0.02 | Why? |
Viral Envelope Proteins | 1 | 2017 | 3539 | 0.02 | Why? |
Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
Epitopes | 1 | 2017 | 4113 | 0.02 | Why? |
Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
Base Sequence | 1 | 2012 | 3581 | 0.02 | Why? |
Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
Travel | 1 | 2020 | 7220 | 0.01 | Why? |
Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
Child | 2 | 2021 | 70012 | 0.01 | Why? |
Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
Health Policy | 1 | 2018 | 6242 | 0.01 | Why? |
Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
Vero Cells | 1 | 2012 | 14117 | 0.01 | Why? |
Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
Aged | 2 | 2021 | 215776 | 0.01 | Why? |
China | 1 | 2020 | 50654 | 0.01 | Why? |
Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |